Financials
- Market Capitalization 4.31 B
- Employee 137
- Founded 2017
- CEO N/A
- Website www.tangotx.com
- Headquarter Delaware, United States
- FIGI BBG00WFDDRS0
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-25.2
Fiyat/satışlar oranı
43.08
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1426 | VKTX Viking Therapeutics, Inc. - Common Stock | 37.61 USD | -0.95% | -7.07% | +27.49% | +20.35% | 4.37 B USD | ||
| 1436 | ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 25.43 USD | -0.24% | -3.27% | +19.22% | +15.17% | 4.35 B USD | ||
| 1450 | EWTX Edgewise Therapeutics, Inc. - Common Stock | 39.34 USD | -0.98% | -12.50% | +10.17% | +158.31% | 4.23 B USD | ||
| 1529 | NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 32.20 USD | -3.27% | -11.73% | +5.40% | -11.22% | 3.76 B USD |